We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Phase I/II Trial Evaluating the Anti-Vascular Endothelial Growth Factor Monoclonal Antibody Bevacizumab in Combination With the HER-1/Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Erlotinib for Patients With Recurrent Non–Small-Cell Lung Cancer
- Authors
Herbst, Roy S.; Johnson, David H.; Mininberg, Eric; Carbone, David P.; Henderson, Ted; Kim, Edward S.; Blumenschein, George Jr; Lee, Jack J.; Liu, Diane D.; Truong, Mylene T.; Hong, Waun K.; Tran, Hai; Tsao, Anne; Xie, Dong; Ramies, David A.; Mass, Robert; Seshagiri, Somasekar; Eberhard, David A.; Kelley, Sean K.; Sandler, Alan
- Publication
Journal of Clinical Oncology, 2005, Vol 23, Issue 11, p2544
- ISSN
0732-183x
- Publication type
article
- DOI
10.1200/jco.2005.02.477